Cell phone data to monitor spread of infectious diseases

Vast datasets from tracking mobile phone data could allow health professionals to track the infectious diseases that spread each season. Read More »

New polio vaccine to benefit over four million Pakistani children each year

A new inactivated polio vaccine (IPV) will help another polio-endemic country step closer to a polio-free future, as it will benefit more than four million children in Pakistan each year. Read More »

iBio to gain U.S. patent for novel influenza therapeutic product

iBio Inc., a pioneer in plant-based biotechnology that creates and produces biopharmaceutical products, recently received notice that its U.S. patent for the company’s monoclonal antibody targeting influenza will be issued on Aug. 26, 2015. Read More »

Mumps cases continue to spread in Illinois

Health professionals recently confirmed that there have been additional new cases of mumps at the University of Illinois, Urbana-Champaign. Read More »

Abbott improves managing TB and multidrug-resistant TB

Abbott Laboratories recently said its RealTime MTB and  RealTime MTB RIF/INH Resistance assays improve the management of tuberculosis and multidrug-resistant TB (MDR-TB). Read More »

Study: Mowing dry basins can boost mosquito activity, West Nile risk

A recent University of Illinois study on the risk of West Nile virus with “dry” water-detention basins in Central Illinois indicated that mowing these dry basins worsens mosquito problems. The researchers said mowing wetland plants inside basins that have not properly drained can cause a rapid increase in Culex pipiens mosquito populations, which can carry and transmit West Nile virus. Read More »

Action plan to end severe poverty by 2030 approved at Gavi conference

Gavi, the Vaccine Alliance, recently held a global conference about financing development platforms to achieve Sustainable Development Goals (SDGs). Government leaders and representatives from several nations recently attended the Financing for Development conference, where they approved the Addis Ababa Action Agenda. Read More »

North Dakota reports first West Nile virus case of 2015

The North Dakota Department of Health (NDDoH) recently confirmed the state’s first West Nile virus human case for 2015. Read More »

AMA encourages stricter vaccination opt outs

Doctors suggest limiting exemptions to medical reasons only. Read More »

Takeda consolidates US vaccine sites in Boston

Takeda Pharmaceutical Co. Ltd. recently announced that it will begin to consolidate the company’s Vaccine Business Unit (VBU) operations throughout the Boston and Cambridge area. Read More »

Researchers exploit HIV's "sweet tooth" to weaken virus

Researchers recently discovered that HIV has a "sweet tooth" for sugar and nutrients from activated immune cells, which may prove to be the cell’s weak spot where scientists can administer treatments for patients. Read More »

Potential vaccine may lower blood pressure

According to new research from Hypertension, a journal from the American Heart Association, a future vaccine may help to lower blood pressure over the long term. Read More »

Takeda to distribute seasonal flu vaccines in Japan

Takeda Pharmaceutical Co. Ltd. recently announced that it has partnered with the Chemo-Sero-Therapeutic Research Institute to distribute Kaketsuken’s seasonal influenza vaccine throughout Japan. Read More »

Measles may compromise immune systems for three years

A recent study by Princeton University researchers shows children’s immune systems may be compromised for up to three years after contracting the measles virus. Read More »

Interferon-free therapy treats hepatitis C in trial

A recent trial shows that interferon-free therapy has cleared hepatitis C from 93 percent of the patients involved in the trial. Read More »

Study reveals no connection between MMR vaccine and autism

A recent study published in the Journal of American Medical Association shows there is no connection between the MMR (measles, mumps, and rubella) vaccine and autism rates. Read More »

Chronic hepatitis C treatment given priority review in Japan

Abbie's ombitasvir/paritaprever/ritonavir treatment is ribavrin- and interferon-free. Read More »

Study shows Illinois college students lack measles immunizations

According to a report from NBC 5 Investigates, over one-third of colleges and universities in Illinois have allowed students to live on campus without having proof of receiving measles vaccinations and over half of those schools allowed students without immunizations to live on campus at rates considered to be risky by many health professionals. Read More »

Takeda transfers HPV vaccine license to Kaketsuken

Takeda Pharmaceutical Company, Ltd., has recently transferred its license agreement for a vaccine for human papillomavirus (HPV) to Kaketsuken, the Chemo-Sero-Therapeutic Research Institute. Read More »

Takeda halts DTaP-sIP vaccine development

Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan and Asia, recently announced that it has discontinued the development of TAK-361S vaccine, which was in clinical development Phase 2. Read More »